Search - tctmd.com

Displaying 281 - 300 of 302

Sort: Relevancy | Date

Presentation TVT 2012

Frequency and Reasons for Mitral Valve Replacement Rather Than Repair: Is It the Patients or the Surgeons?

Presenter: Michael Mack

June 05, 2012

Presentation TVT 2012

Case Study 2: Recurrent MR After Surgical Repair for Functional MR

Presenter: David Adams

June 05, 2012

Presentation TVT 2012

Case Study 1: Recurrent MR After Surgical Repair for Degenerative MR

Presenter: Allan Schwartz

June 05, 2012

Presentation TVT 2012

Are the Quality and Durability of MV Repairs Improving?

Presenter: Thomas Walther

June 05, 2012

Presentation TVT 2012

The Spectrum of Evolving Mitral Repair Techniques

Presenter: David Adams

June 04, 2012

Presentation

Percutaneous Mitral Valve Repair: Where Do We Stand in 2012?

Presenter: D. Scott Lim

May 02, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Daily News

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

February 07, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

Presentation

Acute and 12-Mo Results with Catheter-Based Mitral Valve Leaflet Repair: EVEREST II High Risk Study

Presenter: Patrick L. Whitlow

January 04, 2012

Presentation TCT 2012

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

Presenter: Maurizio Taramasso, Paolo Denti, Micaela Cioni, Nicola Buzzatti, Antonio Colombo, Ottavio Alfieri, Francesco Maisano

January 03, 2012

News Conference News

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

November 07, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

News Industry News

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

March 28, 2011

Advertisement

Frequency and Reasons for Mitral Valve Replacement Rather Than Repair: Is It the Patients or the Surgeons?

Case Study 2: Recurrent MR After Surgical Repair for Functional MR

Case Study 1: Recurrent MR After Surgical Repair for Degenerative MR

Are the Quality and Durability of MV Repairs Improving?

The Spectrum of Evolving Mitral Repair Techniques

Percutaneous Mitral Valve Repair: Where Do We Stand in 2012?

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Experts Give Their Picks for Most Important Developments of 2011

Mitral Repair Can Augment Heart Function in CABG Patients

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Acute and 12-Mo Results with Catheter-Based Mitral Valve Leaflet Repair: EVEREST II High Risk Study

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

Abbott to Present New Data for Key Vascular Products at TCT 2011

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content